GXIGerresheimer AG
25.14EUR-6.89%Mkt Cap: 851.07M EURP/E: 36.24Last update: 2026-05-14

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)36.24
P/E (Forward)9.25
PEG1.23
P/B0.61
P/S0.38
EV/EBITDA7.90
EV/Revenue1.35
EPS (TTM)0.68
EPS (Forward)2.67
Cash Flow & Leverage
FCF Yield-66.59%
FCF Margin-25.18%
Operating CF240.33M EUR
CapEx (TTM)369.85M EUR
Net Debt/EBITDA5.62
Net Debt2.16B EUR
Technical
SMA 5021.14 (+18.9%)
SMA 20027.88 (-9.8%)
Beta0.45
S&P 52W Chg24.23%
Avg Vol (30d)291.55K
Avg Vol (10d)326.46K
Technical Indicators
RSI (14)56.9
MACD1.8593
MACD Signal1.7509
MACD Hist.+0.1083
BB Upper29.12 EUR
BB Middle24.41 EUR
BB Lower19.71 EUR
BB Width38.53%
ATR (14)1.622 EUR
Vol Ratio (20d)0.82x
52W Range
14.8320% of range66.50
52W High66.50 EUR
52W Low14.83 EUR
Profitability
Gross Margin29.85%
EBITDA Margin17.11%
Profit Margin5.39%
Oper. Margin1.32%
ROE7.26%
ROA2.88%
Revenue Growth12.50%
Earnings Growth
Balance Sheet
Debt/Equity0.85
Current Ratio0.98
Quick Ratio0.41
Book Value/Sh40.59 EUR
Cash/Share4.223 EUR
Dividends
Fwd Div Rate0.0400 EUR
Trail. Div Rate0.0400 EUR
Div. Yield0.16%
5Y Avg Yield1.36%
Payout Ratio5.88%
Ex-Div DateJun 6, 2025
Pay Date
Ownership
Shares Out.34.54M
Float32.05M
Insiders10.97%
Institutions92.40%
Analyst Consensus
Rating3.2 (Hold)
Target (Mean)24.04 EUR
Target Range12.50 EUR46.00 EUR
# Analysts11
Company
Market Cap851.07M EUR
Enterprise Value3.04B EUR
Revenue (TTM)2.25B EUR
Gross Profit607.76M EUR
Net Income (TTM)109.72M EUR
Revenue/Share65.15 EUR
Fiscal Year EndNov 2024
MR QuarterAug 2025
Employees13.5K
Last Price25.14 EUR
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE000A0LD6E6